RSV Vaccination

Vaccination for pregnant women

A single dose of the RSV vaccine, Abrysvo®, will be provided to pregnant women who are between 28-36 weeks into their pregnancy under the National Immunisation Program (NIP) from 3 February 2025. Maternal RSV vaccine is administered to protect newborn infants, through the passing of Respiratory Syncytial Virus (RSV) specific antibodies from the mother to the unborn baby.

Vaccination for older Australians

Vaccination is the most effective way to protect yourself against common winter respiratory viruses, including respiratory syncytial virus (RSV). By staying up to date with recommended vaccinations, you can help reduce your risk of serious illness. People aged 75 years and over are at highest risk of severe illness and hospitalisation from RSV. The National Immunisation Program (NIP) offers vaccinations free of charge to people with a Medicare card, aged 75 years or over.